Document Detail


Cost-effectiveness of open partial fasciectomy, needle aponeurotomy, and collagenase injection for dupuytren contracture.
MedLine Citation:
PMID:  21981831     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: We undertook a cost-utility analysis to compare traditional fasciectomy for Dupuytren with 2 new treatments, needle aponeurotomy and collagenase injection.
METHODS: We constructed an expected-value decision analysis model with an arm representing each treatment. A survey was administered to a cohort of 50 consecutive subjects to determine utilities of different interventions. We conducted multiple sensitivity analyses to assess the impact of varying the rate of disease recurrence in each arm of the analysis as well as the cost of the collagenase injection. The threshold for a cost-effective treatment is based on the traditional willingness-to-pay of $50,000 per quality-adjusted life years (QALY) gained.
RESULTS: The cost of open partial fasciectomy was $820,114 per QALY gained over no treatment. The cost of needle aponeurotomy was $96,474 per QALY gained versus no treatment. When we performed a sensitivity analysis and set the success rate at 100%, the cost of needle aponeurotomy was $49,631. When needle aponeurotomy was performed without surgical center or anesthesia costs and with reduced hand therapy, the cost was $36,570. When a complete collagenase injection series was priced at $250, the cost was $31,856 per QALY gained. When the injection series was priced at $945, the cost was $49,995 per QALY gained. At the market price of $5,400 per injection, the cost was $166,268 per QALY gained.
CONCLUSIONS: In the current model, open partial fasciectomy is not cost-effective. Needle aponeurotomy is cost-effective if the success rate is high. Collagenase injection is cost-effective when priced under $945.
TYPE OF STUDY/LEVEL OF EVIDENCE: Economic and Decision Analysis II.
Authors:
Neal C Chen; Melissa J Shauver; Kevin C Chung
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, N.I.H., Extramural     Date:  2011-10-05
Journal Detail:
Title:  The Journal of hand surgery     Volume:  36     ISSN:  1531-6564     ISO Abbreviation:  J Hand Surg Am     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-10-31     Completed Date:  2012-02-27     Revised Date:  2012-03-02    
Medline Journal Info:
Nlm Unique ID:  7609631     Medline TA:  J Hand Surg Am     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1826-1834.e32     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 American Society for Surgery of the Hand. Published by Elsevier Inc. All rights reserved.
Affiliation:
Department of Orthopaedic Surgery and the Section of Plastic Surgery, University of Michigan Medical School, Ann Arbor, MI, USA. nealchen@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Analysis of Variance
Cohort Studies
Collagenases / economics,  therapeutic use*
Cost-Benefit Analysis
Cross-Sectional Studies
Decision Support Techniques
Dupuytren Contracture / economics*,  surgery*,  therapy
Fascia / surgery*
Female
Follow-Up Studies
Hospital Costs*
Humans
Injections, Intralesional
Male
Middle Aged
Orthopedic Procedures / economics*,  methods
Quality-Adjusted Life Years
Recovery of Function
Recurrence
Risk Assessment
Severity of Illness Index
Surgical Procedures, Minimally Invasive / economics,  methods
Treatment Outcome
Grant Support
ID/Acronym/Agency:
K24 AR053120/AR/NIAMS NIH HHS
Chemical
Reg. No./Substance:
EC 3.4.24.-/Collagenases
Comments/Corrections
Comment In:
J Hand Surg Am. 2012 Feb;37(2):394; author reply 394-5   [PMID:  22281175 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Intra-Articular Fractures of the Distal Radius Evaluated by Computed Tomography.
Next Document:  SNAP-23 and syntaxin-3 are required for chemokine release by mature human mast cells.